SCAI statement on ad hoc versus the separate performance of diagnostic cardiac catheterization and coronary intervention

被引:13
作者
Blankenship, JC [1 ]
Klein, LW
Laskey, WK
Krone, RJ
Dehmer, GJ
Chambers, C
Cowley, M
机构
[1] Geisinger Med Ctr, Dept Cardiol, Danville, PA 17822 USA
[2] Rush Presbyterian St Lukes Med Ctr, Clin Cardiol Associates, Chicago, IL USA
[3] Uniformed Serv Univ Hlth Sci, Div Cardiol, Bethesda, MD 20814 USA
[4] Washington Univ, Sch Med, Div Cardiol, St Louis, MO USA
[5] Texas A&M Univ, Sch Med, Temple, TX USA
[6] Milton S Hershey Med Ctr, Dept Cardiol, Hershey, PA USA
[7] Virginia Commonwealth Univ, Sch Med, Div Cardiol, Richmond, VA USA
[8] Scott & White Mem Hosp & Clin, Div Cardiol, Temple, TX USA
关键词
angioplasty; stenting; costs;
D O I
10.1002/ccd.20229
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Coronary intervention may be combined with diagnostic cardiac catheterization or performed separately. In the early years of angioplasty, performing these procedures separately was standard practice. Gradually, ad hoc intervention (performing diagnostic angiography and coronary intervention within the same session) has become more common, largely because of its convenience for patients and efficiency for physicians. However, the safety and potential cost savings of this approach remain uncertain. Criteria for the appropriate use of ad hoc intervention have not been established. Ad hoc intervention is reasonable for many, but not appropriate for all patients and should not be considered standard therapy. This document updates an earlier review of this topic and provides suggestions for the use of ad hoc intervention as a routine strategy. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:444 / 451
页数:8
相关论文
共 38 条
[1]   Cost advantages of an ad hoc angioplasty strategy [J].
Adele, C ;
Vaitkus, PT ;
Wells, SK ;
Zehnacker, JB .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (02) :321-325
[2]  
Beauchamp T., 1989, PRINCIPLES BIOMEDICA
[3]   Acetylcysteine for prevention of contrast nephropathy:: meta-analysis [J].
Birck, R ;
Krzossok, S ;
Markowetz, F ;
Schnülle, P ;
van der Woude, FJ ;
Braun, C .
LANCET, 2003, 362 (9384) :598-603
[4]  
Blankenship James C, 2004, Am Heart Hosp J, V2, P52, DOI 10.1111/j.1541-9215.2004.03334.x
[5]  
BLANKENSHIP JC, 2000, CATHETER CARDIOVASC, V491, P30
[6]   SAME-DAY ANGIOPLASTY AND DIAGNOSTIC CATHETERIZATION - SAFE AND EFFECTIVE BUT RISKIER IN UNSTABLE ANGINA [J].
BREISBLATT, WM ;
RUFFNER, RJ ;
URETSKY, BF ;
REDDY, PS .
ANGIOLOGY, 1991, 42 (08) :607-613
[7]   Triple antiplatelet therapy during percutaneous coronary intervention is associated with improved outcomes including one-year survival - Results from the do tirofiban and ReoPro give similar efficacy outcome trial (TARGET) [J].
Chan, AW ;
Moliterno, DJ ;
Berger, PB ;
Stone, GW ;
DiBattiste, PM ;
Yakubov, SL ;
Sapp, SK ;
Wolski, K ;
Bhatt, DL ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (07) :1188-1195
[8]  
DeLuca S A, 1995, J Cardiovasc Nurs, V9, P54
[9]  
Fearon William F, 2003, Rev Cardiovasc Med, V4, P1
[10]   CORONARY ANGIOPLASTY AT THE TIME OF INITIAL CARDIAC-CATHETERIZATION [J].
FELDMAN, RL ;
MACDONALD, RG ;
HILL, JA ;
CONTI, R ;
PEPINE, CJ ;
CARMICHAEL, MJ ;
KNAUFF, DG ;
ALEXANDER, JA .
CATHETERIZATION AND CARDIOVASCULAR DIAGNOSIS, 1986, 12 (04) :219-222